BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 27766447)

  • 1. Relationship Between β-Amyloid and Mitochondrial Dynamics.
    Kim DI; Lee KH; Oh JY; Kim JS; Han HJ
    Cell Mol Neurobiol; 2017 Aug; 37(6):955-968. PubMed ID: 27766447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cell type-specific mitochondrial dysfunction in the pathogenesis of Alzheimer's disease.
    Kim DK; Mook-Jung I
    BMB Rep; 2019 Dec; 52(12):679-688. PubMed ID: 31722781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Molecular Pathways and Therapeutic Implications Targeting Mitochondrial Dysfunction for Alzheimer's Disease.
    Dhapola R; Sarma P; Medhi B; Prakash A; Reddy DH
    Mol Neurobiol; 2022 Jan; 59(1):535-555. PubMed ID: 34725778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic cerebral hypoperfusion accelerates Alzheimer's disease pathology with the change of mitochondrial fission and fusion proteins expression in a novel mouse model.
    Feng T; Yamashita T; Zhai Y; Shang J; Nakano Y; Morihara R; Fukui Y; Hishikawa N; Ohta Y; Abe K
    Brain Res; 2018 Oct; 1696():63-70. PubMed ID: 29879414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CR6-interacting factor 1 is a key regulator in Aβ-induced mitochondrial disruption and pathogenesis of Alzheimer's disease.
    Byun J; Son SM; Cha MY; Shong M; Hwang YJ; Kim Y; Ryu H; Moon M; Kim KS; Mook-Jung I
    Cell Death Differ; 2015 Jun; 22(6):959-73. PubMed ID: 25361083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer's Disease.
    Cabezas-Opazo FA; Vergara-Pulgar K; Pérez MJ; Jara C; Osorio-Fuentealba C; Quintanilla RA
    Oxid Med Cell Longev; 2015; 2015():509654. PubMed ID: 26221414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid Beta Peptide-Mediated Alterations in Mitochondrial Dynamics and its Implications for Alzheimer's Disease.
    Monsalvo-Maraver LÁ; Maya-López M; Rangel-López E; Túnez I; Tinkov AA; Skalny A; Ferrer B; Aschner M; Santamaría A
    CNS Neurol Disord Drug Targets; 2023; 22(7):1039-1056. PubMed ID: 35713133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cell model for the initial phase of sporadic Alzheimer's disease.
    Stockburger C; Gold VA; Pallas T; Kolesova N; Miano D; Leuner K; Müller WE
    J Alzheimers Dis; 2014; 42(2):395-411. PubMed ID: 24898661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Mitochondrial Dysfunction in the Pathology of Amyloid-β.
    Huang Z; Yan Q; Wang Y; Zou Q; Li J; Liu Z; Cai Z
    J Alzheimers Dis; 2020; 78(2):505-514. PubMed ID: 33044180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease.
    Verri M; Pastoris O; Dossena M; Aquilani R; Guerriero F; Cuzzoni G; Venturini L; Ricevuti G; Bongiorno AI
    Int J Immunopathol Pharmacol; 2012; 25(2):345-53. PubMed ID: 22697066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's pathogenesis and its link to the mitochondrion.
    Simoncini C; Orsucci D; Caldarazzo Ienco E; Siciliano G; Bonuccelli U; Mancuso M
    Oxid Med Cell Longev; 2015; 2015():803942. PubMed ID: 25973139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide links mitochondrial fission to Alzheimer's disease.
    Westermann B
    Sci Signal; 2009 May; 2(69):pe29. PubMed ID: 19417214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial import and degradation of amyloid-β peptide.
    Pinho CM; Teixeira PF; Glaser E
    Biochim Biophys Acta; 2014 Jul; 1837(7):1069-74. PubMed ID: 24561226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial dysfunction and Alzheimer's disease.
    Maruszak A; Żekanowski C
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):320-30. PubMed ID: 20624441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial Dysfunction in Neocortex and Hippocampus of Olfactory Bulbectomized Mice, a Model of Alzheimer's Disease.
    Avetisyan AV; Samokhin AN; Alexandrova IY; Zinovkin RA; Simonyan RA; Bobkova NV
    Biochemistry (Mosc); 2016 Jun; 81(6):615-23. PubMed ID: 27301290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.
    Manczak M; Anekonda TS; Henson E; Park BS; Quinn J; Reddy PH
    Hum Mol Genet; 2006 May; 15(9):1437-49. PubMed ID: 16551656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial traffic jams in Alzheimer's disease - pinpointing the roadblocks.
    Correia SC; Perry G; Moreira PI
    Biochim Biophys Acta; 2016 Oct; 1862(10):1909-17. PubMed ID: 27460705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria, mitochondrial DNA and Alzheimer's disease. What comes first?
    Mancuso M; Orsucci D; Siciliano G; Murri L
    Curr Alzheimer Res; 2008 Oct; 5(5):457-68. PubMed ID: 18855587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of mitochondrial amyloid-beta in Alzheimer's disease.
    Chen JX; Yan SS
    J Alzheimers Dis; 2010; 20 Suppl 2():S569-78. PubMed ID: 20463403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease: effects of β-amyloid on mitochondria.
    Tillement L; Lecanu L; Papadopoulos V
    Mitochondrion; 2011 Jan; 11(1):13-21. PubMed ID: 20817045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.